HOUSE 133118th CongressReferred to the House Committee on the Judiciary.
Expressing the sense of the House of Representatives with respect to Marcus Garvey.
- Last Action
- 2/17/2023
Actions
- 2024-12-19Placed on the Union Calendar, Calendar No. 779.
- 2024-12-19Committee on Ways and Means discharged.
- 2024-12-19Committee on Ways and Means discharged.
- 2024-12-17Referred to the Subcommittee on Health.
- 2024-11-22House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
- 2024-11-22Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
- 2024-11-22Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
- 2023-12-06Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
- 2023-12-06Committee Consideration and Mark-up Session Held
- 2023-12-05Committee Consideration and Mark-up Session Held
- 2023-11-15Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.
- 2023-11-15Subcommittee Consideration and Mark-up Session Held
- 2023-01-20Referred to the Subcommittee on Health.
- 2023-01-09Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-01-09Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Showing 15 of 17 actions. Full history on Congress.gov.
CRS Summary
As of 2023-01-09 (00)
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Cosponsors (6)
- Nanette Barragan (D-CA)
- Maria Salazar (R-FL)
- Brian Fitzpatrick (R-PA)
- A. Ferguson (R-GA)
- Mike Carey (R-OH)
- Carol Miller (R-WV)
Subjects
- Medical research
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.